Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-006765
Filing Date
2025-05-07
Accepted
2025-05-07 16:46:19
Documents
70
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rytm-20250331x10q.htm   iXBRL 10-Q 1961509
2 EX-31.1 rytm-20250331xex31d1.htm EX-31.1 12882
3 EX-31.2 rytm-20250331xex31d2.htm EX-31.2 14599
4 EX-32.1 rytm-20250331xex32d1.htm EX-32.1 6880
5 EX-32.2 rytm-20250331xex32d2.htm EX-32.2 7949
  Complete submission text file 0001558370-25-006765.txt   7672180

Data Files

Seq Description Document Type Size
6 EX-101.SCH rytm-20250331.xsd EX-101.SCH 50597
7 EX-101.CAL rytm-20250331_cal.xml EX-101.CAL 55864
8 EX-101.DEF rytm-20250331_def.xml EX-101.DEF 217403
9 EX-101.LAB rytm-20250331_lab.xml EX-101.LAB 470231
10 EX-101.PRE rytm-20250331_pre.xml EX-101.PRE 340984
73 EXTRACTED XBRL INSTANCE DOCUMENT rytm-20250331x10q_htm.xml XML 1080864
Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Filer) CIK: 0001649904 (see all company filings)

EIN.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38223 | Film No.: 25922196
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)